Research Paper Volume 13, Issue 5 pp 7499—7516
BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma
Figure 1. BDKRB2 expression in CGGA and TCGA dataset according to WHO grade (A, E), IDH mutation status (B, F), TCGA molecular subtype (C, G) and ROC curves (D, H) for distinguishing mesenchymal subtype. * indicates p value < 0.05, **indicates p value < 0.01, *** indicates p value < 0.001, **** indicates p value < 0.0001.